Pharmacokinetics and pharmacodynamics of Piperacillin-Tazobactam (PT) in pediatric oncology patients with fever and neutropenia.

Trial Profile

Pharmacokinetics and pharmacodynamics of Piperacillin-Tazobactam (PT) in pediatric oncology patients with fever and neutropenia.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 02 Mar 2018

At a glance

  • Drugs Piperacillin/tazobactam (Primary)
  • Indications Fever
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Mar 2018 Status changed from not yet recruiting to recruiting.
    • 05 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top